Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzi Lizhong Pill is a classic traditional Chinese medicine (TCM) formula used primarily to "warm and reinforce the spleen and stomach" according to TCM theory. It is indicated for deficiency-cold syndrome of the spleen and stomach, manifesting as cold sensation and pain in the epigastrium, vomiting, diarrhea, cold extremities, bloating, indigestion, abdominal pain and other digestive complaints[1][6][8]. The formula contains processed aconite root (Radix Aconiti Lateralis Preparata), codonopsis root (Radix Codonopsis), white atractylodes rhizome (Rhizoma Atractylodis Macrocephalae), dried ginger rhizome (Rhizoma Zingiberis), and licorice root (Radix Glycyrrhizae)[1][6][8]. Modern research suggests it may regulate gut microbiota composition[3], modulate energy metabolism pathways relevant to gastrointestinal health[3], support immune function in the gut mucosa[6], and has shown antidepressant-like effects in animal models under chronic stress conditions[2]. It is widely used as an OTC herbal remedy for various digestive disorders including gastritis, IBS-Diarrhea type (IBS-D), gastric ulcers and general symptoms of Spleen Yang Deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzi Lizhong Pill.